The prognostic role of BRCA mutations in ovarian and breast cancer is well established; BRCA2 mutated breast cancer displays worse prognosis compared to sporadic cancer, while, in BRCA1, no substantial differences were observed [16]. The gene discussed is BRCA2; the disease is breast cancer.